• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Tuesday

    3/21/23 1:35:39 PM ET
    $ACDC
    $ADCT
    $ADMP
    $AG
    Oilfield Services/Equipment
    Energy
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACDC alert in real time by email

     

    On Tuesday, 74 companies achieved new lows for the year.

    Points of Interest From Today's 52-Week Lows:

    • First Majestic Silver (NYSE:AG) was the biggest company in terms of market cap to set a new 52-week low.
    • The smallest company by market cap to hit a new 52-week low was Dunxin Financial Hldgs (AMEX:DXF).
    • Qutoutiao (NASDAQ:QTT) made the largest move down on the session, with shares plummeting 57.39% to reach its 52-week low.
    • Angel Oak Financial (NYSE:FINS)'s stock rebounded the most, as it traded up 0.0% after dropping to a new 52-week low.

    The stocks that set new 52-week lows on Tuesday:

    • First Majestic Silver (NYSE:AG) stock dropped to a yearly low on Tuesday of $5.56. Shares traded down 24.19%.
    • Centerspace (NYSE:CSR) shares fell to $52.74 on Tuesday, setting a new 52-week low with a shift of up 0.28%.
    • ProFrac Holding (NASDAQ:ACDC) shares made a new 52-week low of $13.07 on Tuesday. The stock was down 7.84% for the day.
    • YS Biopharma Co (NASDAQ:YS) shares set a new 52-week low of $7.44. The stock traded down 8.82%.
    • Mineralys Therapeutics (NASDAQ:MLYS) shares moved down 5.39% on Tuesday to hit a new 52-week low of $13.54, drifting down 5.39%.
    • Microvision (NASDAQ:MVIS) shares hit a yearly low of $2.06. The stock was down 0.94% on the session.
    • Nuveen Preferred & Income (NYSE:JPI) stock broke to a new 52-week low of $16.24 on Tuesday. Shares of the company traded down 0.92%.
    • Orion Office REIT (NYSE:ONL) stock achieved a new 52-week low on Tuesday morning, hitting $5.73 and moving up 0.69%.
    • John Hancock Preferred (NYSE:HPF) stock achieved a new 52-week low on Tuesday morning, hitting $14.69 and moving down 0.41%.
    • Angel Oak Financial (NYSE:FINS) shares reached a new 52-week low of $12.33 on Tuesday morning, moving 0.0% (flat).
    • Consolidated Comms Hldgs (NASDAQ:CNSL) stock drifted down 0.62% on Tuesday morning to hit a new 52-week low of $2.37.
    • Grindrod Shipping Hldgs (NASDAQ:GRIN) stock hit a yearly low of $11.20. The stock was down 1.1% for the day.
    • Cohen & Steers Select (NYSE:PSF) stock dropped to a yearly low on Tuesday of $17.60. Shares traded down 1.79%.
    • OrganiGram Holdings (NASDAQ:OGI) stock hit $0.59 on Tuesday morning, setting a new 52-week low for a change of up 5.89%.
    • ADC Therapeutics (NYSE:ADCT) shares made a new 52-week low of $2.08 on Tuesday. The stock was up 1.19% for the day.
    • Nektar Therapeutics (NASDAQ:NKTR) stock hit a new 52-week low of $0.86. The stock was down 4.43% on the session.
    • Focus Universal (NASDAQ:FCUV) stock hit $3.54 on Tuesday morning, setting a new 52-week low for a change of down 2.62%.
    • Beachbody Co (NYSE:BODY) shares set a new yearly low of $0.49 this morning. The stock was down 2.28% on the session.
    • Selina Hospitality (NASDAQ:SLNA) shares reached a new 52-week low of $1.35 on Tuesday morning, moving down 1.43%.
    • Azure Power Global (NYSE:AZRE) stock dropped to a yearly low on Tuesday of $1.62. Shares traded down 4.97%.
    • Kore Group Holdings (NYSE:KORE) stock hit $1.22 on Tuesday morning, setting a new 52-week low for a change of up 10.0%.
    • Berkeley Lights (NASDAQ:BLI) shares moved down 7.06% on Tuesday to hit a new 52-week low of $1.15, drifting down 7.06%.
    • VBI Vaccines (NASDAQ:VBIV) stock broke to a new 52-week low of $0.23 on Tuesday. Shares of the company traded up 2.8%.
    • ImmunoPrecise Antibodies (NASDAQ:IPA) shares hit a yearly low of $2.90. The stock was up 0.65% on the session.
    • Solid Biosciences (NASDAQ:SLDB) shares moved up 2.44% on Tuesday to hit a new 52-week low of $3.63, drifting up 2.44%.
    • Nuveen Preferred (NYSE:JPT) shares made a new 52-week low of $16.05 on Tuesday. The stock was down 3.91% for the day.
    • Longeveron (NASDAQ:LGVN) stock drifted down 3.89% on Tuesday morning to hit a new 52-week low of $2.56.
    • SMX (Security Matters) (NASDAQ:SMX) stock hit a yearly low of $1.32. The stock was up 0.73% for the day.
    • Silvergate Capital (NYSE:SI) shares set a new yearly low of $1.46 this morning. The stock was down 11.31% on the session.
    • Portage Biotech (NASDAQ:PRTG) stock hit a yearly low of $2.59. The stock was down 5.3% for the day.
    • MIND C.T.I. (NASDAQ:MNDO) shares made a new 52-week low of $2.00 on Tuesday. The stock was down 11.3% for the day.
    • ReWalk Robotics (NASDAQ:RWLK) stock drifted down 1.34% on Tuesday morning to hit a new 52-week low of $0.66.
    • SELLAS Life Sciences Gr (NASDAQ:SLS) shares moved down 0.78% on Tuesday to hit a new 52-week low of $1.23, drifting down 0.78%.
    • MAIA Biotechnology (AMEX:MAIA) stock dropped to a yearly low on Tuesday of $3.10. Shares traded up 1.57%.
    • BM Technologies (AMEX:BMTX) stock dropped to a yearly low on Tuesday of $2.60. Shares traded down 3.64%.
    • Avalo Therapeutics (NASDAQ:AVTX) shares set a new 52-week low of $2.07. The stock traded up 1.85%.
    • Urban-gro (NASDAQ:UGRO) stock broke to a new 52-week low of $2.48 on Tuesday. Shares of the company traded up 1.56%.
    • Knightscope (NASDAQ:KSCP) shares set a new yearly low of $0.64 this morning. The stock was up 0.77% on the session.
    • E-Home Household Service (NASDAQ:EJH) stock broke to a new 52-week low of $0.10 on Tuesday. Shares of the company traded down 3.74%.
    • Atlis Motor Vehicles (NASDAQ:AMV) shares hit a yearly low of $0.67. The stock was up 0.71% on the session.
    • Aziyo Biologics (NASDAQ:AZYO) shares fell to $1.18 on Tuesday, setting a new 52-week low with a shift of down 15.17%.
    • Vaccinex (NASDAQ:VCNX) shares fell to $0.39 on Tuesday, setting a new 52-week low with a shift of down 2.52%.
    • FlexShopper (NASDAQ:FPAY) stock hit a new 52-week low of $0.74. The stock was down 1.92% on the session.
    • Adamis Pharmaceuticals (NASDAQ:ADMP) shares fell to $0.10 on Tuesday, setting a new 52-week low with a shift of up 3.06%.
    • SHF Hldgs (NASDAQ:SHFS) shares moved down 2.73% on Tuesday to hit a new 52-week low of $0.53, drifting down 2.73%.
    • Angion Biomedica (NASDAQ:ANGN) shares set a new yearly low of $0.47 this morning. The stock was up 0.1% on the session.
    • Sigmatron International (NASDAQ:SGMA) shares fell to $2.42 on Tuesday, setting a new 52-week low with a shift of down 20.77%.
    • CXApp (NASDAQ:CXAI) shares moved down 2.38% on Tuesday to hit a new 52-week low of $1.81, drifting down 2.38%.
    • Bullfrog AI Hldgs (NASDAQ:BFRG) stock achieved a new 52-week low on Tuesday morning, hitting $2.47 and moving up 2.39%.
    • Better Choice Co (AMEX:BTTR) stock broke to a new 52-week low of $0.41 on Tuesday. Shares of the company traded down 2.06%.
    • AgriFORCE Growing Systems (NASDAQ:AGRI) shares set a new yearly low of $0.65 this morning. The stock was down 4.62% on the session.
    • PolyPid (NASDAQ:PYPD) shares were down 2.62% for the day, having made a 52-week low of $0.50.
    • Check-Cap (NASDAQ:CHEK) shares reached a new 52-week low of $1.60 on Tuesday morning, moving down 41.9%.
    • Plus Therapeutics (NASDAQ:PSTV) stock dropped to a yearly low on Tuesday of $0.27. Shares traded 0.0% (flat).
    • Qutoutiao (NASDAQ:QTT) stock broke to a new 52-week low of $0.25 on Tuesday. Shares of the company traded down 57.39%.
    • Athenex (NASDAQ:ATNX) shares set a new yearly low of $0.98 this morning. The stock was down 18.26% on the session.
    • Soligenix (NASDAQ:SNGX) shares fell to $2.13 on Tuesday, setting a new 52-week low with a shift of up 4.4%.
    • SILO Pharma (NASDAQ:SILO) shares moved down 8.33% on Tuesday to hit a new 52-week low of $1.71, drifting down 8.33%.
    • IT Tech Packaging (AMEX:ITP) stock hit a yearly low of $0.44. The stock was down 0.02% for the day.
    • PolarityTE (NASDAQ:PTE) shares set a new 52-week low of $0.62. The stock traded down 1.32%.
    • Reliance Global Group (NASDAQ:RELI) stock achieved a new 52-week low on Tuesday morning, hitting $2.51 and moving down 1.55%.
    • Bellicum Pharmaceuticals (NASDAQ:BLCM) shares reached a new 52-week low of $0.27 on Tuesday morning, moving up 7.03%.
    • Dunxin Financial Hldgs (AMEX:DXF) stock hit a yearly low of $0.12. The stock was down 2.99% for the day.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $ACDC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACDC
    $ADCT
    $ADMP
    $AG

    CompanyDatePrice TargetRatingAnalyst
    PLUS THERAPEUTICS Inc.
    $PSTV
    2/3/2026$2.00Buy
    Lake Street
    Avalo Therapeutics Inc.
    $AVTX
    2/2/2026$50.00Buy
    Guggenheim
    Organigram Global Inc.
    $OGI
    1/27/2026Buy
    Canaccord Genuity
    Avalo Therapeutics Inc.
    $AVTX
    12/18/2025$39.00Outperform
    Mizuho
    Solid Biosciences Inc.
    $SLDB
    12/4/2025$16.00Buy
    Needham
    Nektar Therapeutics
    $NKTR
    11/26/2025$102.00Buy
    Citigroup
    D/B/A Centerspace
    $CSR
    11/12/2025Strong Buy → Mkt Perform
    Raymond James
    First Majestic Silver Corp.
    $AG
    10/8/2025Hold → Buy
    TD Securities
    More analyst ratings

    $ACDC
    $ADCT
    $ADMP
    $AG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    INVESTMENT ADVISER PRINCIPAL Prabhu Sreeniwas bought $118,535 worth of shares (9,203 units at $12.88), increasing direct ownership by 6% to 175,180 units (SEC Form 4)

    4 - Angel Oak Financial Strategies Income Term Trust (0001745059) (Issuer)

    1/30/26 1:19:50 PM ET
    $FINS
    Finance/Investors Services
    Finance

    INVESTMENT ADVISER PRINCIPAL Fierman Michael bought $214,087 worth of shares (16,220 units at $13.20), increasing direct ownership by 15% to 125,420 units (SEC Form 4)

    4 - Angel Oak Financial Strategies Income Term Trust (0001745059) (Issuer)

    1/30/26 9:54:49 AM ET
    $FINS
    Finance/Investors Services
    Finance

    Director Phelan Kenneth J bought $10,001 worth of Common Shares of Beneficial Interest (618 units at $16.18) (SEC Form 4)

    4 - JOHN HANCOCK PREFERRED INCOME FUND II (0001189740) (Issuer)

    1/27/26 4:04:53 PM ET
    $HPF
    Finance Companies
    Finance

    $ACDC
    $ADCT
    $ADMP
    $AG
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-5) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:04:01 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-4) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:03:14 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for FAMOTIDINE issued to ATHENEX INC

    Submission status for ATHENEX INC's drug FAMOTIDINE (SUPPL-13) with active ingredient FAMOTIDINE has changed to 'Approval' on 01/07/2022. Application Category: ANDA, Application Number: 075684, Application Classification: Labeling

    1/12/22 4:41:30 AM ET
    $ATNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACDC
    $ADCT
    $ADMP
    $AG
    SEC Filings

    View All

    SHF Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - SHF Holdings, Inc. (0001854963) (Filer)

    2/9/26 8:35:53 AM ET
    $SHFS
    Finance: Consumer Services
    Finance

    SEC Form 424B3 filed by SMX (Security Matters) Public Limited Company

    424B3 - SMX (Security Matters) Public Ltd Co (0001940674) (Filer)

    2/9/26 6:03:49 AM ET
    $SMX
    Industrial Machinery/Components
    Technology

    SEC Form 6-K filed by SMX (Security Matters) Public Limited Company

    6-K - SMX (Security Matters) Public Ltd Co (0001940674) (Filer)

    2/6/26 11:45:33 AM ET
    $SMX
    Industrial Machinery/Components
    Technology

    $ACDC
    $ADCT
    $ADMP
    $AG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on Plus Therapeutics with a new price target

    Lake Street initiated coverage of Plus Therapeutics with a rating of Buy and set a new price target of $2.00

    2/3/26 8:52:26 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    Guggenheim initiated coverage on Avalo Therapeutics with a new price target

    Guggenheim initiated coverage of Avalo Therapeutics with a rating of Buy and set a new price target of $50.00

    2/2/26 6:51:00 AM ET
    $AVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Canaccord Genuity initiated coverage on Organigram Global

    Canaccord Genuity initiated coverage of Organigram Global with a rating of Buy

    1/27/26 9:29:20 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACDC
    $ADCT
    $ADMP
    $AG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Operating Officer Howton David T sold $121,713 worth of shares (18,894 units at $6.44), decreasing direct ownership by 16% to 97,859 units (SEC Form 4)

    4 - Solid Biosciences Inc. (0001707502) (Issuer)

    2/6/26 6:05:06 PM ET
    $SLDB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    President and CEO Cumbo Alexander sold $315,093 worth of shares (48,913 units at $6.44), decreasing direct ownership by 18% to 222,018 units (SEC Form 4)

    4 - Solid Biosciences Inc. (0001707502) (Issuer)

    2/6/26 6:01:54 PM ET
    $SLDB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Ganot Ilan sold $46,414 worth of shares (7,205 units at $6.44) (SEC Form 4)

    4 - Solid Biosciences Inc. (0001707502) (Issuer)

    2/6/26 6:01:49 PM ET
    $SLDB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACDC
    $ADCT
    $ADMP
    $AG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Safe Harbor Financial Announces Extension with PCCU Generating an Estimated $9 Million Incremental Revenue Through 2031

    DENVER, Feb. 09, 2026 (GLOBE NEWSWIRE) -- SHF Holdings, Inc., d/b/a Safe Harbor Financial ("Safe Harbor" or "the Company") (NASDAQ:SHFS), a leading fintech platform serving the banking, lending, and financial services requirements of the regulated cannabis and hemp industries, today announced a transformational amendment to its Commercial Alliance Agreement with Partner Colorado Credit Union ("PCCU") that fundamentally improves the Company's economics and positions it for accelerated, profitable growth. The amended agreement extends our customer relationship through December 2031 from its original 2029 expiration date with automatic two-year renewal provisions, fundamentally enhancing the

    2/9/26 8:30:00 AM ET
    $SHFS
    Finance: Consumer Services
    Finance

    Solid Biosciences Announces Positive Feedback from Type C Meeting with FDA for SGT-003 Gene Therapy for Duchenne Muscular Dystrophy

    - IMPACT DUCHENNE: Company aligned with FDA on Phase 3 randomized, double-blind, placebo-controlled trial design -- IMPACT DUCHENNE: Company anticipates first participant dosing in Q1 2026 - - Company plans for additional meetings with the FDA in 1H 2026 to align on a potential accelerated approval pathway for SGT-003 - - INSPIRE DUCHENNE: SGT-003 continues to be generally well tolerated with 36 participants dosed as of February 9, 2026, in Phase 1/2 trial - CHARLESTOWN, Mass., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ:SLDB) (the "Company" or "Solid"), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today anno

    2/9/26 8:00:00 AM ET
    $SLDB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    The domestic service industry will continue to be exempt from value-added tax, and the 2026 tax reform will promote the sustainable and high-quality development of China's domestic service sector

    FUZHOU, China, Feb. 6, 2026 /PRNewswire/ -- E-Home Household Services Holdings Limited (NASDAQ:EJH) (the "Company" or "eHome"), an integrated home services provider in China, announced today that the company will fully leverage new tax incentives to enhance financial management, strengthen training for domestic service personnel, improve service quality, and introduce AI technology. The company will progressively roll out a human-machine integrated service model and make effective use of tax benefits to increase staff deployment rates, propelling its performance to new heights by 2026. Key support directions for China's 2026 tax policies targeting the domestic service industry: 1. Domestic

    2/6/26 8:30:00 AM ET
    $EJH
    Other Consumer Services
    Consumer Discretionary

    $ACDC
    $ADCT
    $ADMP
    $AG
    Leadership Updates

    Live Leadership Updates

    View All

    Safe Harbor Bolsters Lending Capabilities and Client Experience with Strategic Leadership Hires

    DENVER, Dec. 30, 2025 (GLOBE NEWSWIRE) -- SHF Holdings, Inc., d/b/a Safe Harbor (the "Company") (NASDAQ:SHFS), a fintech leader in providing banking, lending and financial services to the regulated cannabis and hemp industries, announced the addition of two key executives to its leadership team. Stephen La Rosa joins Safe Harbor as Senior Vice President, Lending Strategy and Partner Development and Cassandra Douglas as Senior Manager Client Experience and Onboarding. These hires represent a proactive investment in the people and capabilities required to support cannabis operators across their full financial lifecycle — from onboarding and compliance to capital access and long-term growth.

    12/30/25 8:00:00 AM ET
    $SHFS
    Finance: Consumer Services
    Finance

    PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors

    PETACH TIKVA, Israel, Dec. 16, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (NASDAQ:PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced the appointment of Brooke Story as Chairman of the Board of Directors, effective as of December 11, 2025. "Brooke's appointment marks an exciting and pivotal moment for PolyPid," said Dikla Czaczkes Akselbrad, Chief Executive Officer of PolyPid. "Her global expertise in the surgical market, specifically in infection prevention and advanced surgical solutions, combined with her extensive experience leading corporate strategy and corporate development transactions, will be instrumental in transfor

    12/16/25 8:30:00 AM ET
    $PYPD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    First Majestic Reports Continued Exploration Success at Santa Elena and Announces Senior Management Update

    New drilling significantly expands the gold and silver mineralization of the Santo Niño and Navidad discoveriesDrilling completed at Luna expected to convert substantial amount of Inferred Mineral Resources to Indicated Mineral ResourcesStart of scoping-level studies for Navidad and Santo Niño provide guidance on potential mining strategiesMani Alkhafaji promoted to President & Chief Corporate Development OfficerVancouver, British Columbia--(Newsfile Corp. - December 15, 2025) - First Majestic Silver Corp. (NYSE:AG) (TSX:AG) (FSE: FMV) (the "Company" or "First Majestic") is pleased to announce the start of preliminary mine planning studies for the Navidad and Santo Niño discoveries located a

    12/15/25 4:30:00 PM ET
    $AG
    Precious Metals
    Basic Materials

    $ACDC
    $ADCT
    $ADMP
    $AG
    Financials

    Live finance-specific insights

    View All

    Organigram to Report First Quarter Fiscal 2026 Results on February 10, 2026

    Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share, announced today it will report earnings results for its first quarter fiscal 2026 ended December 31, 2025, on Tuesday, February 10, 2026, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, February 10, 2026 Time: 8:00 am Eastern Time To register for the conference call, please use this link: https://events.q4inc.com/analyst/430252525?pwd=WEt2KbHS To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call.

    2/3/26 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    JOHN HANCOCK CLOSED-END FUNDS DECLARE MONTHLY DISTRIBUTIONS

    BOSTON, Feb. 2, 2026 /PRNewswire/ - The John Hancock closed-end funds listed below declared their monthly distributions today as follows: Declaration Date:          February 2, 2026 Ex Date:                      February 12, 2026 Record Date:              February 12, 2026 Payment Date:            February 27, 2026 Ticker Fund Name Distribution Per Share  Change FromPrevious Distribution Market Price as of 1/30/2026 Annualized Current Distribution Rate at Market HPI Preferred Income Fund I $0.1235 - $16.21 9.14 % HPF Preferred Income Fund II $0.1235 - $16.14 9.18 % HPS Preferred Income Fund III $0.1100 - $14.68 8.99 % PDT Premium Dividend Fund $0.0825 - $12.99 7.62 % HTD Tax-Advantaged Divi

    2/2/26 4:12:00 PM ET
    $HPF
    $HPI
    $HPS
    Finance Companies
    Finance
    Trusts Except Educational Religious and Charitable
    Investment Managers

    PolyPid to Report Fourth Quarter 2025 Financial Results and Operational Highlights on February 11, 2026

    PETACH TIKVA, Israel, Jan. 28, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (NASDAQ:PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its fourth quarter 2025 financial results and operational highlights before the open of the U.S. financial markets on Wednesday, February 11, 2026. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations. To ensure you are connected prior to the beginning of the call, PolyPid suggests registering a minimum of 5 minutes before the start of the call. For those not planning to ask a question

    1/28/26 8:00:00 AM ET
    $PYPD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACDC
    $ADCT
    $ADMP
    $AG
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at urban-gro Inc. on Jun 6

    Urban-gro Inc. saw an interesting insider purchase on June 6, 2024, when Wilks Lewis bought $29,000 worth of shares, acquiring 20,000 units at a price of $1.45 per unit. This transaction increased Lewis' direct ownership by 12% to 184,108 units, as reported in SEC Form 4. Insider transactions like this can provide valuable insights for investors, indicating confidence in the company's future prospects. Analyzing the insider activity surrounding Urban-gro Inc., we can observe several transactions that may reveal patterns or insights. Looking back at previous filings, on September 1, 2023, Wilks Lewis purchased $10,300 worth of shares, acquiring 10,000 units at $1.03 per unit. This

    6/10/24 12:49:49 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    $ACDC
    $ADCT
    $ADMP
    $AG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by PolyPid Ltd.

    SC 13G/A - PolyPid Ltd. (0001611842) (Subject)

    12/12/24 7:05:07 AM ET
    $PYPD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Organigram Holdings Inc.

    SC 13D/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

    12/10/24 7:10:15 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by PolyPid Ltd.

    SC 13G/A - PolyPid Ltd. (0001611842) (Subject)

    11/29/24 1:20:33 PM ET
    $PYPD
    Biotechnology: Pharmaceutical Preparations
    Health Care